Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-020904
Filing Date
2014-03-17
Accepted
2014-03-17 14:06:07
Documents
2
Period of Report
2014-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4292
2 POA DOCUMENT poa.txt EX-24.3_514510 4569
  Complete submission text file 0001209191-14-020904.txt   10417
Mailing Address 12790 EL CAMINO REAL C/O NEUROCRINE BIOSCIENCES SAN DIEGO CA 92130
Business Address
WIERENGA WENDALL (Reporting) CIK: 0001235945 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36310 | Film No.: 14697040

Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Issuer) CIK: 0001367920 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations